Dudediligence.

Clene Inc

CLNNNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

12.8M

on 2026-06-30, from 6.42M on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-20 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$160.0M

S-3 of 2025-03-24. 3 prospectus supplements filed under it since. S-3 ↗

$25.0M

Agreement of 2025-04-28. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-14 is not read yet.

Cash

2.4 quarters

$9.7M on 2026-06-30 ÷ $4.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-09-15Public offering1,219,513$3.28$4.0M424B5 ↗
2026-05-05Public offering1,000,000$7.00$7.0M424B5 ↗
2026-01-08Public offering928,333$6.50$6.0M424B5 ↗
2025-03-27Public offering35,311$3.54not read424B5 ↗